Efficacy of niraparib on progression-free survival (PFS) in patients (pts) with recurrent ovarian cancer (OC) with partial response (PR) to the last platinum-based chemotherapy

被引：9
|
作者：
Mirza, Mansoor Raza
Monk, Bradley J.
Gil-Martin, Marta
Gilbert, Lucy
Canzler, Ulrich
Follana, Philippe
Waters, Justin S.
Kridelka, Frederic
Levy, Tally
Benigno, Benedict B.
Woie, Kathrine
Provencher, Diane M.
Lueck, Hans-Joachim
Herraez, Antonio Casado
Lesoin, Anne
Buscema, Joseph
Hellman, Kristina
Rimel, B. J.
Hazard, Sebastien
Matulonis, Ursula A.
机构：
[1] Nord Soc Gynecol Oncol NSGO, Copenhagen, Denmark
[2] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark
[3] Univ Arizona, Coll Med, Arizona Oncol US Oncol Network, Phoenix, AZ USA
[4] Creighton Univ, Sch Med, St Josephs Hosp, Phoenix, AZ USA
[5] Grp Espanol Invest Canc Ovario GEICO, Barcelona, Spain
[6] IDIBELL, Catalan Inst Oncol, Barcelona, Spain
[7] McGill Univ, Hlth Ctr, Montreal, PQ, Canada
[8] AGO, Dresden, Germany
[9] Tech Univ Dresden, Dept Gynecol & Obstet, Dresden, Germany
[10] Ctr Antoine Lacassagne, Nice, France
[11] GINECO, Nice, France
[12] Maidstone and Tunbridge Wells NHS Trust, Maidstone, Kent, England
[13] NCRI, Maidstone, Kent, England
[14] Domaine Univ Sart Tilman, CHU Liege, Liege, Belgium
[15] Belgium & Luxembourg Gynaecol Oncol Grp BGOG, Liege, Belgium
[16] Edith Wolfson Med Ctr, Holon, Israel
[17] ISGO, Holon, Israel
[18] Univ Gynecol Oncol, Atlanta, GA USA
[19] Univ Bergen, Bergen, Norway
[20] NSGO, Bergen, Norway
[21] Ctr Hosp Univ Montreal CHUM, Montreal, PQ, Canada
[22] Facharzt Frauenheilkunde Gynaekol Onkol P, Hannover, Germany
[23] HCS Carlos, Madrid, Spain
[24] Ctr Oscar Lambret, Dept Cancerol Senol, Lille, France
[25] GEICO, Lille, France
[26] Arizona Oncol Associates, Tucson, AZ USA
[27] Karolinska Univ Sjukhus, Stockholm, Sweden
[28] NSGO, Stockholm, Sweden
[29] Cedars Sinai Med Ctr, Hollywood, CA USA
[30] TESARO Inc, Waltham, MA USA
[31] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.5517
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5517
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Safety and Efficacy of Niraparib in Elderly Patients (Pts) with Recurrent Ovarian Cancer (OC)
    Fabbro, M.
    Moore, K. N.
    Dorum, A.
    Tinker, A. V.
    Mahner, S.
    Bover, I.
    Banerjee, S.
    Tognon, G.
    Goffin, F.
    Shapira-Frommer, R.
    Wenham, R. M.
    Hellman, K.
    Provencher, D. M.
    Harter, P.
    Palacio Vazquez, I.
    Follana, P.
    Pineda, M. J.
    Mirza, M. R.
    Hazard, S. J.
    Matulonis, U. A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [2] Progression-free survival of niraparib in patients with platinum-sensitive recurrent ovarian cancer: meta-analysis
    Purushotama, N. B. S. A.
    Budianto, C. J.
    Sabran, M. Z.
    Hutauruk, C. E. O. L.
    Kurniawan, A.
    Huang, I.
    ANNALS OF ONCOLOGY, 2024, 35 : S1403 - S1403
  • [3] Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial
    del Campo, Josep M.
    Matulonis, Ursula A.
    Malander, Susanne
    Provencher, Diane
    Mahner, Sven
    Follana, Philippe
    Waters, Justin
    Berek, Jonathan S.
    Woie, Kathrine
    Oza, Amit M.
    Canzler, Ulrich
    Gil-Martin, Marta
    Lesoin, Anne
    Monk, Bradley J.
    Lund, Bente
    Gilbert, Lucy
    Wenham, Robert M.
    Benigno, Benedict
    Arora, Sujata
    Hazard, Sebastien J.
    Mirza, Mansoor R.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (32) : 2968 - +
  • [4] Redox protein expression predicts progression-free and overall survival in ovarian cancer patients treated with platinum-based chemotherapy
    Woolston, Caroline M.
    Deen, Suha
    Al-Attar, Ahmad
    Shehata, Mohamed
    Chan, Stephen Y.
    Martin, Stewart G.
    FREE RADICAL BIOLOGY AND MEDICINE, 2010, 49 (08) : 1263 - 1272
  • [5] FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy
    Ison, Gwynn
    Howie, Lynn J.
    Amiri-Kordestani, Laleh
    Zhang, Lijun
    Tang, Shenghui
    Sridhara, Rajeshwari
    Pierre, Vadryn
    Charlab, Rosane
    Ramamoorthy, Anuradha
    Song, Pengfei
    Li, Fang
    Yu, Jingyu
    Manheng, Wimolnut
    Palmby, Todd R.
    Ghosh, Soma
    Horne, Hisani N.
    Lee, Eunice Y.
    Philip, Reena
    Dave, Kaushalkumar
    Chen, Xiao Hong
    Kelly, Sharon L.
    Janoria, Kumar G.
    Banerjee, Anamitro
    Eradiri, Okponanabofa
    Dinin, Jeannette
    Goldberg, Kirsten B.
    Pierce, William F.
    Ibrahim, Amna
    Kluetz, Paul G.
    Blumenthal, Gideon M.
    Beaver, Julia A.
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2018, 24 (17) : 4066 - 4071
  • [6] Efficacy and safety of niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer with complete or partial response to the last platinum-based chemotherapy: a subgroup analysis of the phase III NORA trial
    Yang, Jiaxin
    Wu, Xiaohua
    Zhu, Jianqing
    Song, Liang
    Feng, Yanling
    Wang, Jing
    Wu, Lingying
    Liu, Ziling
    Gao, Yunong
    Wang, Danbo
    Lou, Ge
    Yang, Hongying
    Zhou, Qi
    Kong, Beihua
    Huang, Yi
    Chen, Lipai
    Li, Guiling
    An, Ruifang
    Wang, Ke
    Zhang, Yu
    Yan, Xiaojian
    Lu, Xin
    Wang, Li
    Tan, Tao
    Dong, Juan
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S18 - S18
  • [7] Budget impact of niraparib as maintenance treatment in recurrent ovarian cancer following platinum-based chemotherapy
    Neeser, Kurt
    O'Neil, William M.
    Stern, Lee
    Harrow, Brooke
    Travers, Karin
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (08) : 577 - 587
  • [8] Calpain-2 expression is associated with response to platinum based chemotherapy, progression-free and overall survival in ovarian cancer
    Storr, Sarah J.
    Safuan, Sabreena
    Woolston, Caroline M.
    Abdel-Fatah, Tarek
    Deen, Suha
    Chan, Stephen Y.
    Martin, Stewart G.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2012, 16 (10) : 2422 - 2428
  • [9] Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer
    C K Lee
    R J Simes
    C Brown
    S Lord
    U Wagner
    M Plante
    I Vergote
    C Pisano
    G Parma
    A Burges
    H Bourgeois
    T Högberg
    J Bentley
    L Angleitner-Boubenizek
    A Ferrero
    B Richter
    H Hirte
    V Gebski
    J Pfisterer
    E Pujade-Lauraine
    M Friedlander
    British Journal of Cancer, 2011, 105 : 1144 - 1150
  • [10] Atezolizumab does not improve progression-free survival in patients with recurrent platinum-sensitive ovarian cancer
    Gotlieb, Walter H.
    Tzur, Yossi
    GYNECOLOGY AND PELVIC MEDICINE, 2024, 7
12345